Extensible object oriented framework for general ledger

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The International Business Machines Corporation patent solves the following problem:

This creation account in the general data processing system and, in particular, object oriented programming systems and processes.

Our analysis of this patent is as follows:

International Business Machines Corporation’s patent US 6684384 B1 deals with Extensible object oriented framework for general ledger.
An object oriented framework provides a set of things to do in the general ledger functioning and allow a building user to add extensions to the framework for specific parts of the process, as a a general ledger application program for the management of business financial data to a group. The structure includes an Application class category covering the company information for the general ledger processing, a Publication Activities category of classes that define valid activity posting to the general ledger, a journal category of class performance, process, validate, and post general ledger journal, a Bank Transactions category of class processing bank statements, a Bank statements and reconciliation category of class reconciliation of bank statements with accounts at the bank, and a Closing category classes to validate and close the current accounting period. These classes provide the base structure upon which a general ledger application programs and user structure.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Methods and devices for use in performing pulmonary procedures

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Emphasys Medical, Inc. patent solves the following problem:

The present invention relates generally to methods and devices for use in performing the pulmonary system, and particularly, methods for the treatment of various diseases of the lungs.

Our analysis of this patent is as follows:

Emphasys Medical, Inc.’s patent US 6679264 B1 deals with Methods and devices for use in performing pulmonary procedures.
Systems, methods and devices for performing the procedures in the lungs, and in particular treating emphysema. A flow control element includes a valve that prevents airflow in the inhalation airflow direction but allows the exhalation direction. The flow control element guided and position in place of a bronchoscope that is introduced into the trachea of ​​a patient and used to see the lungs during the delivery of the flow control element. The valve may include one, two or more valve elements, and is collapsible for easier delivery. A source of vacuum or suction can be used to increase the amount of fluid removed from lung tissue. A device to measure hollow structures, such as the bronchioles, and a device for taking a previously-set flow control elements expressed as well.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Detection and confirmation of nucleic acid sequences by use of poisoning oligonucleotides

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Curagen Corporation patent solves the following problem:

As molecular biological and genetics research that age, it becomes more clear that the temporal and spatial expression of the gene plays an important role in the process that took place in both health and disease. Moreover, in the field of Biology increased from an understanding of how genetic defects cause the traditional recognized inherited disorder (for example, the thalassemias), to a realization of the importance of the interaction of many genetic defects in concert with various things in the etiology of many more complex diseases, such as Tumor.

Our analysis of this patent is as follows:

Curagen Corporation’s patent US 6673577 B1 deals with Detection and confirmation of nucleic acid sequences by use of poisoning oligonucleotides.
The present invention discloses a method that aims to provide positive confirmation of nucleic acid, which holds the putatively identified sequences predicted to generate noticed GeneCalling signal, really present in samples from where the original signal obtained. The putatively identified nucleic acid fragments in the sample obtained 3- and 5-terminal end of the known subsequences. methods include contacting nucleic acid fragments in a sample of rearing conditions with (i) a nucleic acid polymerase; (Ii) regular primer oligonucleotides containing sequences comprising hybridizable of known subsequences terminal; and (iii) a dizziness oligonucleotide primer. Nucleic acid amplified by a poisoning primer are known for detection of nucleic acid amplified with primers regularly.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.